1. Home
  2. BCYC vs THRY Comparison

BCYC vs THRY Comparison

Compare BCYC & THRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCYC
  • THRY
  • Stock Information
  • Founded
  • BCYC 2009
  • THRY 2012
  • Country
  • BCYC United Kingdom
  • THRY United States
  • Employees
  • BCYC N/A
  • THRY N/A
  • Industry
  • BCYC Biotechnology: Pharmaceutical Preparations
  • THRY Industrial Machinery/Components
  • Sector
  • BCYC Health Care
  • THRY Industrials
  • Exchange
  • BCYC Nasdaq
  • THRY Nasdaq
  • Market Cap
  • BCYC 492.1M
  • THRY 580.8M
  • IPO Year
  • BCYC 2019
  • THRY 2020
  • Fundamental
  • Price
  • BCYC $6.90
  • THRY $12.69
  • Analyst Decision
  • BCYC Buy
  • THRY Strong Buy
  • Analyst Count
  • BCYC 11
  • THRY 5
  • Target Price
  • BCYC $22.91
  • THRY $21.40
  • AVG Volume (30 Days)
  • BCYC 233.2K
  • THRY 449.5K
  • Earning Date
  • BCYC 10-30-2025
  • THRY 11-06-2025
  • Dividend Yield
  • BCYC N/A
  • THRY N/A
  • EPS Growth
  • BCYC N/A
  • THRY N/A
  • EPS
  • BCYC N/A
  • THRY N/A
  • Revenue
  • BCYC $19,281,000.00
  • THRY $758,289,000.00
  • Revenue This Year
  • BCYC N/A
  • THRY N/A
  • Revenue Next Year
  • BCYC $0.27
  • THRY N/A
  • P/E Ratio
  • BCYC N/A
  • THRY N/A
  • Revenue Growth
  • BCYC N/A
  • THRY N/A
  • 52 Week Low
  • BCYC $6.10
  • THRY $10.03
  • 52 Week High
  • BCYC $28.67
  • THRY $20.92
  • Technical
  • Relative Strength Index (RSI)
  • BCYC 39.17
  • THRY 47.55
  • Support Level
  • BCYC $6.84
  • THRY $12.52
  • Resistance Level
  • BCYC $7.32
  • THRY $13.30
  • Average True Range (ATR)
  • BCYC 0.36
  • THRY 0.51
  • MACD
  • BCYC 0.01
  • THRY -0.03
  • Stochastic Oscillator
  • BCYC 14.56
  • THRY 35.39

About BCYC Bicycle Therapeutics plc

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.

About THRY Thryv Holdings Inc.

Thryv Holdings Inc is dedicated to supporting local, independent service-based businesses and emerging franchises by providing a cloud-based software platform, and marketing solutions to entrepreneurs. Its company is built upon a rich legacy in the marketing and advertising industry. The group are provider of SaaS all-in-one small business management software in addition to providing print and digital marketing solutions to SMBs. Its solutions enable SMB clients to attract and generate new business leads, manage their customer relationships efficiently with artificial intelligence (AI) tools and automation, and run their day-to-day operations to save time, compete and win in today's SMB environment. The group has two business segments; Thryv SaaS and Thryv Marketing Services.

Share on Social Networks: